User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Search

Displaying 3 results.
    • Journal article
    Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.
    Javle, Milind Lowery, Maeve Shroff, Rachna T Weiss, Karl Heinz Springfeld, Christoph Borad, Mitesh J Ramanathan, Ramesh K Goyal, Lipika Sadeghi, Saeed Macarulla, Teresa El-Khoueiry, Anthony Kelley, Robin Kate Borbath, Ivan[UCL] Choo, Su Pin Oh, Do-Youn Philip, Philip A Chen, Li-Tzong Reungwetwattana, Thanyanan Van Cutsem, Eric Yeh, Kun-Huei Ciombor, Kristen Finn, Richard S Patel, Anuradha Sen, Suman Porter, Dale Isaacs, Randi Zhu, Andrew X Abou-Alfa, Ghassan K Bekaii-Saab, Tanios (2018) Journal of Clinical Oncology — Vol. 36, p. 276-282 (2018)
    • Speech
    Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
    Raghav, Kanwal Pratap Singh Yoshino, Takayuki Guimbaud, Rosine Chau, Ian Van den Eynde, Marc[UCL] Maurel, Joan Tie, Jeanne Kim, Tae Won Yeh, Kun-Huei Barrios, Daniel Kobayashi, Kojiro Bako, Emarjola Aregay, Mehreteab Meinhardt, Gerold Siena, Salvatore (2021) 2021 ASCO Annual Meeting I —
    • Speech
    Trastuzumab deruxtecan in patients with HER2-overexpressing locally advanced, unresectable, or metastatic colorectal cancer (mCRC): A randomized, multicenter, phase 2 study (DESTINY-CRC02).
    Raghav, Kanwal Pratap Singh Yoshino, Takayuki Guimbaud, Rosine Chau, Ian Van den Eynde, Marc[UCL] Maurel, Joan Tie, Jeanne Kim, Tae Won Yeh, Kun-Huei Barrios, Daniel Kobayashi, Kojiro Bako, Emarjola Aregay, Mehreteab Meinhardt, Gerold Siena, Salvatore (2022) 2022 ASCO Gastrointestinal Cancers Symposium —